More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

Merck MRK recently intensified its acquisition strategy, actively pursuing deals to enhance its development pipeline and ...

Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18, offering both glycemic control and weight loss ...

Pipeline Therapies, Drugs Sales, and Regional Outlook The report provides a detailed analysis of the current apraxia marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, UNITED STATES, July 14, ...

Validates technological prowess of GAIA platform and intensifies global co-development effort, including the existing partnership with Lilly ...

HONG KONG] The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way ...

AbbVie has entered into a $1 billion licensing agreement with IGI Therapeutics SA, for IGI's lead investigational drug for ...

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

Acquires a highly selective and brain penetrant NLRP3 inhibitor from Mwyngil Therapeutics Company's lead candidate BT-267, a ...

Merck announced plans to acquire Verona Pharma for roughly $10 billion. 1 As part of the agreement between the two companies, Merck will add Verona’s COPD treatment Ohtuvayre to its cardio-pulmonary ...

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.